HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lack of neuroprotective effect of some sigma ligands in a model of focal cerebral ischemia in the mouse.

Abstract
The potential neuroprotective effect of seven sigma ligands has been evaluated in a mouse model of focal cerebral ischemia (induced by coagulation of the left middle cerebral artery) and compared to that of known N-methyl-D-aspartate (NMDA) antagonists. When given after the induction of cerebral ischemia, the NMDA receptor antagonists dizocilpine and CGS 19755 and the mixed NMDA antagonist/sigma ligand eliprodil (SL 82.0715) afforded very substantial protection against cortical infarction (92, 44 and 72%, at the doses of 1, 10 and 10 mg/kg, i.p., for dizocilpine, CGS 19755 and eliprodil, respectively). In contrast, none of the sigma ligands investigated--DTG, DMTG, GBR 12909, (+)- and (-)-3-PPP (up to 10 mg/kg), BMY 14802 (up to 30 mg/kg), except haloperidol at a high dose (3 mg/kg)--had neuroprotective effects.
AuthorsH Poignet, J P Nowicki, B Scatton
JournalBrain research (Brain Res) Vol. 596 Issue 1-2 Pg. 320-4 (Nov 20 1992) ISSN: 0006-8993 [Print] Netherlands
PMID1467996 (Publication Type: Journal Article)
Chemical References
  • Guanidines
  • Isoquinolines
  • Ligands
  • Piperidines
  • Receptors, N-Methyl-D-Aspartate
  • Receptors, sigma
  • PK 11195
  • eliprodil
Topics
  • Animals
  • Brain Ischemia (pathology)
  • Cerebral Cortex (drug effects, metabolism, pathology)
  • Dose-Response Relationship, Drug
  • Guanidines (pharmacology)
  • Isoquinolines (metabolism)
  • Ligands
  • Male
  • Mice
  • Piperidines (pharmacology)
  • Receptors, N-Methyl-D-Aspartate (antagonists & inhibitors)
  • Receptors, sigma (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: